selected scholarly activity
-
conferences
- Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.. Neuro-Oncology. 137-145. 2023
- Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial. International Journal of Radiation Oncology Biology Physics. 1063-1064. 2022
- Effect of Stereotactic Radiosurgery Compared to Whole-brain Radiotherapy for Limited Brain Metastasis on Long Term Cognition and Quality of Life: A Pooled Analysis of NCCTG N107C/CEC.3 and N0574 (Alliance) Randomized Clinical Trials. International Journal of Radiation Oncology Biology Physics. S175-S176. 2020
- Local Control After Resection And Adjuvant Radiosurgery Compared To Radiosurgery Alone For Brain Metastasis: Exploratory Analysis Of Alliance NCCTG N107C. International Journal of Radiation Oncology Biology Physics. e749-e750. 2020
- Steep Dose-response Relationship between Maximum Hippocampal Dose and Memory Deficits following Hippocampal Avoidance Whole Brain Radiation Therapy (HA-WBRT) for Brain Metastases: A Secondary Analysis of NRG/RTOG 0933. International Journal of Radiation Oncology Biology Physics. S176-S176. 2020
- FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402. Neuro-Oncology. 15-15. 2019
- Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3). International Journal of Radiation Oncology Biology Physics. S10-S10. 2019
- CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5-15 BRAIN METASTASES. Neuro-Oncology. 49-49. 2017
- N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease. International Journal of Radiation Oncology Biology Physics. 937-937. 2016
- Evaluation of Pseudoprogression in Patients With Glioblastoma (EPPIG). International Journal of Radiation Oncology Biology Physics. S288-S288. 2014
- Stereotactic Radiosurgery for Refractory Trigeminal Neuralgia. International Journal of Radiation Oncology Biology Physics. S325-S326. 2014
- A Preliminary Series of the Use of Stereotactic Radiosurgery (SBRT) in High-Risk Head-and-Neck Cancer. International Journal of Radiation Oncology Biology Physics. S429-S430. 2013
- Robotic radiosurgery for the treatment of one to three brain metastases: A pragmatic application of cost-benefit analysis using willingness to pay.. Journal of Clinical Oncology. 17-17. 2012
- Fractionated Stereotactic Radiosurgery with Concurrent Temozolomide for Locally Recurrent Glioblastoma Multiforme: A Prospective Study. International Journal of Radiation Oncology Biology Physics. S281-S281. 2011
- 43 Self-shielding character of a tomotherapy unit in a replacement strategy: Economic considerations. Radiotherapy and Oncology. S13-S13. 2006
- PCN27 HEALTH STATUS MEASURES AS PREDICTORS OF MORTALITY AMONG ADULTS WITH BRAIN TUMORS. Value in Health. A112-A112. 2006
- Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index. Cancer. 258-265. 1997
- ENDOCRINE DISORDERS FOLLOWING TREATMENT OF BRAIN-TUMORS IN CHILDHOOD. British Journal of Cancer. 874-874. 1987
- GROWTH FAILURE FOLLOWING IRRADIATION IN CHILDREN WITH BRAIN-TUMORS. British Journal of Cancer. 865-866. 1987
-
journal articles
- QOL-18. HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402. Neuro-Oncology. 25:v252-v252. 2023
- Spindle cell oncocytoma reclassified from amelanotic melanocytoma of the sellar region. Clinical Neuropathology. 42:197-200. 2023
- Surgical Management of Meningiomas Involving the Torcula, Transverse Sinus, and Jugular Bulb: A Technical Note and Review of the Literature. Journal of Neurological Surgery Reports. 84:e92-e102. 2023
- Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro-Oncology. 25:1123-1131. 2023
- Corrigendum to: Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro-Oncology. 25:1010-1010. 2023
- Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. Neuro-Oncology. 25:137-145. 2023
- Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis. JAMA Oncology. 8:1809-1809. 2022
- Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy. Current Oncology. 28:3683-3691. 2021
- A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation. Radiation Oncology. 15:267. 2020
- CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS. Neuro-Oncology. 22:ii40-ii41. 2020
- CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539. Neuro-Oncology. 22:ii55-ii56. 2020
- CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS. Neuro-Oncology. 22:ii40-ii41. 2020
- CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539. Neuro-Oncology. 22:ii55-ii56. 2020
- 25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS. NOA. 2:ii4-ii4. 2020
- 25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS. Neuro-Oncology Advances. 2:ii4-ii4. 2020
- Radiation Necrosis Following Stereotactic Radiosurgery for Trigeminal Neuralgia. Canadian Journal of Neurological Sciences. 47:425-427. 2020
- Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). International Journal of Radiation Oncology Biology Physics. 106:255-260. 2020
- ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402. Neuro-Oncology. 21:vi15-vi15. 2019
- ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402. Neuro-Oncology. 21:vi15-vi15. 2019
- 105 Cyberknife Stereotactic Radiosurgery for Treatment of Benign Intracranial Meningioma: Long-Term Safety and Efficacy. Radiotherapy and Oncology. 139:S46-S47. 2019
- The Future Is Now—Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!. Frontiers in Oncology. 8:380. 2018
- CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN METASTASES. Neuro-Oncology. 19:vi49-vi49. 2017
- NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS. Neuro-Oncology. 19:vi138-vi138. 2017
- Amelanotic melanocytoma of the sella mimicking pituitary adenoma. Clinical Neuropathology. 36:283-287. 2017
- NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS. Neuro-Oncology. 19:vi138-vi138. 2017
- Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. The Lancet Oncology. 18:1049-1060. 2017
- Evaluation of pseudoprogression in patients with glioblastoma. Neuro-Oncology Practice. 4:120-134. 2017
- 65‐year‐old female with cerebellopontine angle lesion. Brain Pathology. 27:237-238. 2017
- Exploration of Morbidity in a Serial Study of Long-Term Brain Tumor Survivors: A Focus on Pain. Journal of Adolescent and Young Adult Oncology. 4:129-136. 2015
- Health-related Quality of Life in Long-term Survivors of Brain Tumors in Childhood and Adolescence. Journal of Pediatric Hematology/Oncology. 37:362-367. 2015
- Clival chordoma metastatic to right lateral ventricle: A case report. Canadian Journal of Neurological Sciences. 41:S15-S15. 2014
- Stereotactic radiosurgery for refractory trigeminal neuralgia. Canadian Journal of Neurological Sciences. 41:S15-S15. 2014
- Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study. OncoTargets and Therapy. 7:485-485. 2014
- Robotic Radiosurgery for the Treatment of 1–3 Brain Metastases: A Pragmatic Application of Cost-Benefit Analysis Using Willingness-To-Pay. Technology in Cancer Research and Treatment. 12:517-523. 2013
- The Technique and Cost of Radiosurgery for the Treatment of 1-3 Brain Metastases. Canadian Journal of Neurological Sciences. 40:795-799. 2013
- Use of Continuous Infusion Pumps During Radiation Treatment. JCO Oncology Practice. 9:107-111. 2013
- Technology Resource Planning in Radiation Oncology: Application of a Needs-Based Analytic Framework to Radiosurgery Planning in Ontario. JCO Oncology Practice. 8:358-362. 2012
- Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada. BMC Health Services Research. 11:178. 2011
- Total quality culture in radiotherapy departments across Ontario. Radiotherapy and Oncology. 99:90-93. 2011
- 167 A PRELIMINARY INVESTIGATION OF TOTAL QUALITY CULTURE IN RADIOTHERAPY DEPARTMENTS ACROSS ONTARIO, CANADA: A PROVINCIAL SURVEY. Radiotherapy and Oncology. 92:S53-S53. 2009
- Organisational Standards for the Delivery of Intensity-modulated Radiation Therapy in Ontario. Clinical Oncology. 21:192-203. 2009
- The Utility of Publicly Reported Cancer Treatment Wait Time Information for Patients and Health Care Providers. Clinical Oncology. 21:218-225. 2009
- Health Status Measurements at Diagnosis As Predictors of Survival Among Adults With Brain Tumors. Journal of Clinical Oncology. 24:3636-3643. 2006
- Who are the users of publicly reported cancer treatment wait times (WT)?. Journal of Clinical Oncology. 24:6043-6043. 2006
- Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the radiation therapy oncology group protocol 91-04. International Journal of Radiation Oncology Biology Physics. 48:59-64. 2000
- Health-related quality of life in survivors of tumours of the central nervous system in childhood—a preference-based approach to measurement in a cross-sectional study1Presented in part to the meetings of the International Society of Pediatric Oncology (SIOP) in Paris, September 1994 and Montevideo, October 1995.1. European Journal of Cancer. 35:248-255. 1999
- Accelerated radiation therapy for primary lymphoma of the brain. Radiotherapy and Oncology. 47:191-195. 1998
- Osteopenia in children surviving brain tumours. European Journal of Cancer. 34:873-877. 1998
- Author reply. Cancer. 82:995-996. 1998
- Self-reported comprehensive health status of adult brain tumor patients using the health utilities index. Cancer. 82:995-995. 1998
- A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the radiation therapy oncology group (RTOG) 9104. International Journal of Radiation Oncology Biology Physics. 39:571-574. 1997
- Self‐reported comprehensive health status of adult brain tumor patients using the Health Utilities Index. Cancer. 80:258-265. 1997
- 2022 Prognosis and management of oligodendrogliomas. International Journal of Radiation Oncology Biology Physics. 36:289-289. 1996
- Child with Wilms' tumor and von Willebrand disease at diagnosis and apparent complete response to chemotherapy after multiple relapses. Pediatric Blood and Cancer. 26:64-69. 1996
- Childhood medulloblastoma in Ontario, 1977–1987: Population-based results. Pediatric Blood and Cancer. 26:1-9. 1996
- Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.. Strahlentherapie und Onkologie. 171:615-621. 1995
- Nitric oxide and anti-cancer therapy. Cancer Treatment Reviews. 21:159-181. 1995
- Abstracts of the 6th Canadian Neuro-Oncology Meeting May 18–21, 1994 Lake Louise, Alberta. Journal of Neuro-Oncology. 19:175-192. 1994
- An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood.. Journal of Pediatric Hematology/Oncology. 15:284-290. 1993
- Medulloblastoma - Ontario provincial review (1977 – 1987). International Journal of Radiation Oncology Biology Physics. 27:263-263. 1993
- Phase I study of hyperfractionated whole brain irradiation (HWBI) in the treatment of primary cerebral lymphoma. Clinical Oncology. 5:159-164. 1993
- Disseminated Langerhans Cell Histiocytosis in Identical Twins Unresponsive to Recombinant Human α-Interferon and Total Body Irradiation. Journal of Pediatric Hematology/Oncology. 14:269-272. 1992
- Management of Children with Acute Lymphoblastic Leukemia by the Dana-Farber Cancer Institute Protocols. Journal of Pediatric Hematology/Oncology. 14:136-139. 1992
- Endocrine disorders following treatment of childhood brain tumours. British Journal of Cancer. 61:622-625. 1990
- Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. International Journal of Radiation Oncology Biology Physics. 18:783-786. 1990
- High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. British Journal of Cancer. 58:779-782. 1988
- Initial experience with Tc-99m-HM-PAO in the study of brain tumors. European Journal of Nuclear Medicine and Molecular Imaging. 14:39-44. 1988
- The effect of storage conditions on amniotic fluid phosphatidylglycerol concentration.. Journal of Perinatology. 8:356-357. 1988
- Growth failure and other endocrine disorders following irradiation of childhood brain tumors. International Journal of Radiation Oncology Biology Physics. 13:88-88. 1987
- Combining backscattered electrons and low energy photons to improve the dose distribution to an eyelid. International Journal of Radiation Oncology Biology Physics. 11:617-620. 1985
- Radiotherapy for jugulo-tympanic paragangliomas (Glomus jugulare tumours). Journal of Laryngology and Otology. 98:621-629. 1984
- Hair Regrowth after Cancer Therapy. Human and Experimental Toxicology. 2:465-472. 1983
- Quantified scoring of the amniotic fluid surfactant foam test and assessment of factors contributing to false negative test results. American Journal of Obstetrics and Gynecology. 145:752-756. 1983